Keeping up to date with New Psychoactive Substances is hard! We've assembled a crack team of experts to help us do just that: Michael Evans-Brown from EMCDDA, Conor Crean from UNODC, and Alex Krotulski from CFSRE.
These updates will be a regular part of our podcast schedule, letting you know about recent developments in NPS markets, detection and harms. In this episode we discuss an increasing trend of xylazine in fentanyl supplies, the recent scheduling of some NPS by the United Nations, and the emergence of semi-synthetic cannabinoids including HHC.
LISTEN NOW
April 20, 2023
